Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteria

Conclusion: PERCIST 1.0 may provide significant prognostic information for patients with mCRPC undergoing systemic chemotherapy, particularly when incorporated with PSA treatment response criteria.

Source: Theranostics - July 3, 2020 Category: Molecular Biology Authors: Erik M. Velez, Bhushan Desai, Lingyun Ji, David I. Quinn, Patrick M. Colletti, Hossein Jadvar Tags: Research Paper Source Type: research